Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Kazia Presents Further Paxalisib and Cantrixil Data at AACR, Reinforcing Positive Efficacy Signals for both Drugs 2020-06-22 12:39
Kazia Presents Interim Paxalisib Phase II Data at ASCO Showing Positive Overall Survival Signal 2020-06-01 08:45
Kazia's Paxalisib Shows Positive Overall Survival Signal in Phase II Glioblastoma Study 2020-04-07 20:00
Kazia Initiates Preparatory Activities to Bring GDC-0084 into GBM AGILE, an International Phase II / III Study in Glioblastoma 2019-12-11 08:41
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference 2019-11-25 07:00
Kazia Raises A$4.0 Million to Progress R&D Programs 2019-10-28 10:16
Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer 2019-09-13 20:00
St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway 2019-09-12 21:10
Kazia to test GDC-0084 with Radiotherapy in Phase I Clinical Trial at Leading US Cancer Center 2019-07-22 09:08
Kazia calls for greater awareness of the deadliest brain cancer in the US 2019-07-17 20:00
Kazia Enters Clinical Collaboration for Metastatic Brain Cancer with Alliance for Clinical Trials in Oncology 2019-05-20 11:41
Kazia calls for greater awareness of the deadliest gynecological cancer in the US 2019-05-08 20:00
Kazia calls for greater awareness of the most lethal women's disease in Australia 2019-05-08 09:55
Kazia Presents Positive Cantrixil Phase I Data at AACR Conference 2019-04-01 11:29
Kazia to present on Cantrixil at American Association for Cancer Research (AACR) 2019 Annual Meeting 2019-03-25 13:25
Kazia Share Purchase Plan Raises A$0.8 Million, Taking Total Funds Raised to A$4.2 Million 2018-11-20 12:53
Progress Update on GDC-0084 Program 2018-10-29 18:00
Kazia Enters Clinical Collaboration to Investigate Use of Brain Cancer Drug GDC-0084 in Breast Cancer 2018-10-22 18:00
Kazia Raises A$3.4 Million to Progress R&D Programs 2018-10-18 09:21
Cantrixil Phase I Study Progresses To Next Stage 2018-10-10 15:15
1 2 3 4